Markets › LSE › 0KSX.L

Quest Diagnostics Incorporated

LSE:0KSX.LHealthcare

——At close · Market cap —

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Revenue	9.4	10.8	9.9	9.3	9.9	11.0	+11.8%
Cost of revenue	5.8	6.6	6.5	6.3	6.7	7.5	+11.7%
Gross profit	3.6	4.1	3.3	3.0	3.1	3.5	+12.0%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—
Selling, general & administrative	1.5	1.7	1.7	1.6	1.7	1.9	+10.9%
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—
Operating expenses	1.5	1.7	1.7	1.8	1.7	1.9	+10.9%
Operating income	2.1	2.4	1.6	1.3	1.4	1.6	+13.3%
Interest expense	0.2	0.2	0.1	0.2	0.2	0.3	+22.6%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	−48.0%
Other income / expense	(0.2)	0.2	(0.4)	(0.2)	(0.2)	(0.2)	−1.3%
Pre-tax income	1.9	2.6	1.2	1.1	1.2	1.4	+15.7%
Income tax	0.5	0.6	0.3	0.2	0.3	0.3	+15.0%
Net income	1.4	2.0	0.9	0.9	0.9	1.0	+14.5%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	(0.0)	(0.0)	0.0	0.0	0.0	−100.0%
EPS, basic (per share)	10.68	15.90	8.12	7.59	7.80	8.90	+14.1%
EPS, diluted (per share)	10.52	15.53	7.98	7.52	7.66	8.75	+14.2%
EBITDA	2.4	3.2	1.8	1.7	1.9	2.2	+14.7%
Depreciation & amortization	0.4	0.4	0.4	0.4	0.5	0.6	+15.6%
Weighted average shares (shares)	134,000,000	125,000,000	116,000,000	112,000,000	111,000,000	111,000,000	+0.0%
Weighted average diluted shares (shares)	136,000,000	128,000,000	118,000,000	113,000,000	113,000,000	113,000,000	+0.0%
Gross margin	38.3%	38.4%	33.9%	32.0%	31.9%	31.9%	+0.1 pts
Operating margin	22.3%	22.7%	16.4%	14.4%	14.3%	14.5%	+0.2 pts
Net margin	15.1%	18.4%	9.5%	9.2%	8.8%	9.0%	+0.2 pts

USD billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.